[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)
date : 3/3/2023
Tags: Other Activities
Health and Global Policy Institute (HGPI) Board Member and CEO Mr. Ryoji Noritake has been awarded the FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences. Mr. Noritake was recognized for his contributions to the development of a mature civil society by creating opportunities for diverse stakeholders in society and the parties most affected in various areas to come together for exchanges of opinion that surpass the positions of individuals. At Mr. Noritake’s request, the monetary prize from the award has been donated to HGPI.

■ Introducing the Takemi Memorial Award for Research in Seizon and Life Sciences
The Takemi Memorial Award for Research in Seizon and Life Sciences recognizes individuals or groups who will serve as future leaders of Japan and have made noteworthy achievements through innovative research and practical activities in basic, clinical, and social medicine in life sciences or related fields. (From the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.)
For further details, please refer to the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



